Access Bio Inc

Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, immunochemical diagnostics, biosensors, and molecular diagnostic products worldwide. Its offerings include Covid-19 detection kits for assessing current or past presence of SARS-CoV-2, rapid diagnostic tests for preliminary diagnosis or emergency screening in resource-limited facilities, analyzers for measuring chemicals and other characteristics in biological samples, and molecular diagnostic solutions for analyzing biological markers in the genome and proteome. Products are sold under the CareStart, CareUS, CareSURE, and CareGENE brands. Incorporated in 2002, the company is headquartered in Somerset, New Jersey.